Cynata Therapeutics LimitedASX: CYP

Results of Fully Underwritten Entitlement Offer

· Issued by Cynata Therapeutics Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Cynata Therapeutics Limited reports the results of its fully underwritten entitlement offer, which closed recently. The company received valid applications for a portion of the new shares and entitlement options, indicating a modest take-up rate. The remaining shares will be subscribed for by the underwriter, Caravel Securities Pty Ltd, as per the underwriting agreement. Following the offer, the company expects to raise a total amount before costs.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT 30 October 2026 Results of Fully Underwritten Entitlement Offer Melbourne, Australia; 30 October 2026: Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), advises the results of its fully underwritten pro-rata renounceable entitlement offer...

Cynata Therapeutics Limited on 6ix

Earlier from Cynata Therapeutics

Later from Cynata Therapeutics

All Cynata Therapeutics news releases